首页> 外文会议>International conference on advances in swarm intelligence >Using the Encoder Embedded Framework of Dimensionality Reduction Based on Multiple Drugs Properties for Drug Recommendation
【24h】

Using the Encoder Embedded Framework of Dimensionality Reduction Based on Multiple Drugs Properties for Drug Recommendation

机译:使用基于多种药物属性的降维编码器嵌入式框架进行药物推荐

获取原文

摘要

After obtaining a large amount of drug information, how to extract the most important features from various high-dimensional attribute datasets for drug recommendation has become an important task in the initial stage of drug repositioning. Dimensionality reduction is a necessary and important task for getting the best features in next step. In this paper, three important attribute data about the drugs (i.e., chemical structures, target proteins and side effects) are selected, and two deep frameworks named as F_1 and F_2 are used to accomplish the task of dimensionality reduction. The processed data are used for recommending new indications by collaborative filtering algorithm. In order to compare the results, two important values of Mean Absolute Error (MAE) and Coverage are selected to evaluate the performance of the two frameworks. Through the comparison with the results of Principal Components Analysis (PCA), it shows that the two deep frameworks proposed in this paper perform better than PCA and can be used for dimensionality reduction task in the future in drug repositioning.
机译:在获取大量的药品信息后,如何从各种高维属性数据集中提取最重要的特征进行药品推荐已成为药品重新定位初期的重要任务。降维是获得下一步最佳功能的必要和重要任务。在本文中,选择了有关药物的三个重要属性数据(即化学结构,目标蛋白和副作用),并使用两个名为F_1和F_2的深层框架来完成降维任务。处理后的数据用于通过协同过滤算法推荐新的指示。为了比较结果,选择了两个重要的平均绝对误差(MAE)和覆盖率值来评估两个框架的性能。通过与主成分分析(PCA)的结果进行比较,表明本文提出的两个深层框架比PCA的性能更好,并且可以在将来用于重新定位药物时进行降维任务。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号